Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Israel Hayom) Ran Reznick - Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough drug to treat acute myeloid leukemia (AML), one of the most aggressive cancers. Professor Yinon Ben-Neriah, who heads the research team, said the new drug "targets many leukemia proteins at once and destroys all of the oncogenes [that have the potential to cause cancer], and activates the tumor suppressor P53 gene." Researchers are trying to expand the drug's use to other cancers, including lymphoma, multiple myeloma, melanoma and colorectal cancer. 2018-09-14 00:00:00Full Article
Israeli Researchers Develop Groundbreaking Leukemia Drug
(Israel Hayom) Ran Reznick - Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough drug to treat acute myeloid leukemia (AML), one of the most aggressive cancers. Professor Yinon Ben-Neriah, who heads the research team, said the new drug "targets many leukemia proteins at once and destroys all of the oncogenes [that have the potential to cause cancer], and activates the tumor suppressor P53 gene." Researchers are trying to expand the drug's use to other cancers, including lymphoma, multiple myeloma, melanoma and colorectal cancer. 2018-09-14 00:00:00Full Article
Search Daily Alert
|
Search:
|